Table 1.
Baseline demographic and clinical data, inflammatory, translocation, and other blood markers
| Variable | Rifaximin group | Non-rifaximin group | ||
|---|---|---|---|---|
| Age (years) | 42 (30, 52) | 38 (31,43) | ||
| Gender | Females | 24 | Females | 16 |
| Males | 20 | Males | 25 | |
| BMI (kg/m2) | 21.6 (19.9, 23.2) | 21.5 (20.3, 23.8) | ||
| No. of cases with history of hematemesis | Yes | 27 | Yes | 26 |
| No | 17 | No | 15 | |
| Pulse rate (beats/minute) | 76 (66, 82) | 70 (64, 76) | ||
| Hb (g/dL) | 7.5 (6.2, 11.3) | 9.2 (6.6, 11.0) | ||
| WCC (×109/L) | 2.7 (1.6, 3.5) | 1.8 (1.6, 3.0) | ||
| PLT (×109/L) | 49 (31, 78) | 44 (24, 64) | ||
| MCV (fl) | 80 (67, 87) | 79 (70, 83) | ||
| MPV (mm) | 12.7 (11.2, 13.9) | 12.1 (10.8, 13.6) | ||
| 16S rRNA copies/µL | 129 (23, 499) | 51 (19, 112) | ||
| LPS (ng/mL) | 74 (38, 157) | 154 (45, 649) | ||
| LBP (ng/mL) | 27 (23, 30) | 43 (38, 50) | ||
| TNFR1 (ng/mL) | 1,443 (1,232, 1,911) | 1,495 (1,238, 1,657) | ||
| sCD14 (ng/mL) | 2,402 (1,930, 2,798) | 1,487 (1,299, 1,964) | ||
| Hyaluronan (ng/mL) | 125 (57, 189) | 102 (71, 176) | ||
BMI = body mass index; Hb = hemoglobin; LBP = lipopolysaccharide-binding protein; LPS = lipopolysaccharide; MCV = mean cell volume; MPV = main portal vein diameter; PLT = platelets; sCD14 = soluble cluster of differentiation 14; WCC = white cell count; TNFR1 = tumor necrosis factor receptor 1.
All parameters are represented as median with interquartile range in parenthesis.